Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Etoposide

Etoposide

33419-42-0

DISCOVER
Epirubicine HCl

Epirubicine HCl

56390-09-1

DISCOVER
ERGOTAMINE TARTRATE CRS - * DRUG PRECURSOR (100 MG)

ERGOTAMINE TARTRATE CRS - * DRUG PRECURSOR (100 MG)

379-79-3

DISCOVER
PLASTIC ADDITIVE 21 CRS (100 MG)

PLASTIC ADDITIVE 21 CRS (100 MG)

112-84-5

DISCOVER
ERYTHROMYCIN FOR MICROBIOLOGICAL ASSAY CRS (100 MG)

ERYTHROMYCIN FOR MICROBIOLOGICAL ASSAY CRS (100 MG)

114-07-8

DISCOVER
Enoxacin sesquihydrate

Enoxacin sesquihydrate

84294-96-2

DISCOVER
ERYTHROMYCIN B CRS (25 MG)

ERYTHROMYCIN B CRS (25 MG)

ND

DISCOVER
ERYTHROMYCIN C CRS (25 MG)

ERYTHROMYCIN C CRS (25 MG)

1675-02-1

DISCOVER
Eprosartan mesylate

Eprosartan mesylate

144143-96-4

DISCOVER
Exemestan

Exemestan

107868-30-4

DISCOVER
17beta-Estradiol 3-O-SulfateSodium Salt

17beta-Estradiol 3-O-SulfateSodium Salt

4999-79-5

DISCOVER
ERYTHROMYCIN ESTOLATE CRS (100 MG)

ERYTHROMYCIN ESTOLATE CRS (100 MG)

3521-62-8

DISCOVER